Improving Access for Patients Receiving CAR T-Cell Therapy
Opinion
Video
Experts on multiple myeloma provide clinical insights on unmet needs associated with CAR T-cell therapy, focusing on patient access across academic and community settings.
Dr. Sharma/Dr. Krishnan: What strategies can help community doctors better understand the complications of CAR-T and how do we better coordinate with academic centers to refer back or and which complications can be managed in the community setting?
How can community physicians be trained to recognize and manage CAR-T complications?